FI935318A0 - 15-deoxispergualinanaloger, foerfarande foer deras framstaellning samt deras anvaendning i terapi - Google Patents

15-deoxispergualinanaloger, foerfarande foer deras framstaellning samt deras anvaendning i terapi

Info

Publication number
FI935318A0
FI935318A0 FI935318A FI935318A FI935318A0 FI 935318 A0 FI935318 A0 FI 935318A0 FI 935318 A FI935318 A FI 935318A FI 935318 A FI935318 A FI 935318A FI 935318 A0 FI935318 A0 FI 935318A0
Authority
FI
Finland
Prior art keywords
deoxyspergual
amylated
analogues
derivatives
manufacture
Prior art date
Application number
FI935318A
Other languages
English (en)
Other versions
FI112211B (fi
FI935318A (fi
Inventor
Patrice Renaut
Luc Lebreton
Patrick Dutartre
Philippe Derrepas
Soth Samreth
Original Assignee
Fournier Ind & Sante
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Fournier Ind & Sante filed Critical Fournier Ind & Sante
Publication of FI935318A0 publication Critical patent/FI935318A0/fi
Publication of FI935318A publication Critical patent/FI935318A/fi
Application granted granted Critical
Publication of FI112211B publication Critical patent/FI112211B/fi

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C279/00—Derivatives of guanidine, i.e. compounds containing the group, the singly-bound nitrogen atoms not being part of nitro or nitroso groups
    • C07C279/04—Derivatives of guanidine, i.e. compounds containing the group, the singly-bound nitrogen atoms not being part of nitro or nitroso groups having nitrogen atoms of guanidine groups bound to acyclic carbon atoms of a carbon skeleton
    • C07C279/12—Derivatives of guanidine, i.e. compounds containing the group, the singly-bound nitrogen atoms not being part of nitro or nitroso groups having nitrogen atoms of guanidine groups bound to acyclic carbon atoms of a carbon skeleton being further substituted by nitrogen atoms not being part of nitro or nitroso groups
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/155—Amidines (), e.g. guanidine (H2N—C(=NH)—NH2), isourea (N=C(OH)—NH2), isothiourea (—N=C(SH)—NH2)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C279/00—Derivatives of guanidine, i.e. compounds containing the group, the singly-bound nitrogen atoms not being part of nitro or nitroso groups
    • C07C279/20—Derivatives of guanidine, i.e. compounds containing the group, the singly-bound nitrogen atoms not being part of nitro or nitroso groups containing any of the groups, X being a hetero atom, Y being any atom, e.g. acylguanidines
    • C07C279/24—Y being a hetero atom

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Immunology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Transplantation (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Steroid Compounds (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Macromolecular Compounds Obtained By Forming Nitrogen-Containing Linkages In General (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Peptides Or Proteins (AREA)
  • Curing Cements, Concrete, And Artificial Stone (AREA)
  • Soil Conditioners And Soil-Stabilizing Materials (AREA)
FI935318A 1992-12-02 1993-11-29 Menetelmä terapeuttisesti käyttökelpoisten 15-deoksispergualiinianalogien valmistamiseksi sekä menetelmässä käytettävät välituotteet FI112211B (fi)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR9214517 1992-12-02
FR9214517A FR2698628B1 (fr) 1992-12-02 1992-12-02 Analogues de 15-déoxyspergualine, leur procédé de préparation et leur utilisation en thérapeutique.

Publications (3)

Publication Number Publication Date
FI935318A0 true FI935318A0 (fi) 1993-11-29
FI935318A FI935318A (fi) 1994-06-03
FI112211B FI112211B (fi) 2003-11-14

Family

ID=9436147

Family Applications (1)

Application Number Title Priority Date Filing Date
FI935318A FI112211B (fi) 1992-12-02 1993-11-29 Menetelmä terapeuttisesti käyttökelpoisten 15-deoksispergualiinianalogien valmistamiseksi sekä menetelmässä käytettävät välituotteet

Country Status (24)

Country Link
US (1) US5476870A (fi)
EP (1) EP0600762B1 (fi)
JP (1) JP2945261B2 (fi)
KR (1) KR100187328B1 (fi)
CN (1) CN1045431C (fi)
AT (1) ATE140215T1 (fi)
AU (1) AU664124B2 (fi)
CA (1) CA2110437C (fi)
CZ (1) CZ284958B6 (fi)
DE (1) DE69303583T2 (fi)
DK (1) DK0600762T3 (fi)
ES (1) ES2092263T3 (fi)
FI (1) FI112211B (fi)
FR (1) FR2698628B1 (fi)
GR (1) GR3021269T3 (fi)
HK (1) HK1000467A1 (fi)
HU (1) HU218908B (fi)
NO (1) NO180483C (fi)
NZ (1) NZ250330A (fi)
RU (1) RU2114823C1 (fi)
SK (1) SK280286B6 (fi)
TW (1) TW311132B (fi)
UA (1) UA39920C2 (fi)
ZA (1) ZA938821B (fi)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1996024579A1 (fr) * 1995-02-10 1996-08-15 Fournier Industrie Et Sante Analogues de la 15-deoxyspergualine, leur utilisation en therapeutique et leur procede de preparation
FR2734263B1 (fr) * 1995-05-17 1997-06-20 Fournier Ind & Sante Analogues de la 15-deoxyspergualine, leur procede de preparation et leur utilisation en therapeutique
DE19728436A1 (de) * 1997-07-03 1999-01-07 Niels Franke Niedrigdosierte 15-Desoxyspergualin-Präparate
AU764144B2 (en) * 1998-08-28 2003-08-14 Gryphon Therapeutics, Inc. Polyamide chains of precise length, methods to manufacture them and their conjugates
DE19923961A1 (de) * 1999-05-25 2000-11-30 Euro Nippon Kayaku Gmbh Verwendung von 15-Deoxyspergualin zur Behandlung von hyperreaktiven entzündlichen Erkrankungen und Autoimmunerkrankungen
WO2005105152A2 (en) 2004-05-05 2005-11-10 Atugen Ag Lipids, lipid complexes and use thereof
CN101287497B (zh) 2004-12-27 2013-03-06 赛伦斯治疗公司 涂层脂质复合体和它们的用途
EP2269980A4 (de) 2008-12-24 2011-05-18 Vertex Closed Joint Stock Company Creatinamide, verfahren zu ihrer herstellung und wirkstoff zur ausführung einer neuroprotektiven aktion
RU2428414C2 (ru) 2009-11-03 2011-09-10 Закрытое Акционерное Общество "Вертекс" Способ получения амидов креатина
FR2963238B1 (fr) * 2010-07-29 2012-12-28 Fournier Lab Sa Derives de 15-desoxyspergualine pour le traitement et/ou la prevention des maladies inflammatoires oculaires
CA2806942C (en) * 2010-07-29 2019-06-25 Jocelyne Annat Compounds for the treatment/prevention of ocular inflammatory diseases
KR101695730B1 (ko) 2015-03-10 2017-01-12 하경훈 마늘꼭지 절단기의 절단장치
FR3050455B1 (fr) * 2016-04-26 2019-06-14 Temisis Derives amides des acides polycafeoylquiniques, procede de preparation et utilisations

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5942356A (ja) * 1982-09-02 1984-03-08 Microbial Chem Res Found スパガリン関連化合物およびその製造法
ES2039213T3 (es) * 1986-04-04 1993-09-16 Microbial Chemistry Research Foundation Procedimiento para producir nuevos compuestos relacionados con espergualina.
US5061787A (en) * 1988-06-24 1991-10-29 Nippon Kayaku Kabushiki Kaisha Novel spergualin-related compounds and compositions

Also Published As

Publication number Publication date
AU664124B2 (en) 1995-11-02
HU218908B (hu) 2000-12-28
NO180483C (no) 1997-04-30
KR100187328B1 (ko) 1999-05-15
ES2092263T3 (es) 1996-11-16
NO934338L (no) 1994-06-03
HK1000467A1 (en) 1998-03-27
DE69303583D1 (de) 1996-08-14
US5476870A (en) 1995-12-19
CN1045431C (zh) 1999-10-06
ZA938821B (en) 1994-06-30
NO180483B (no) 1997-01-20
GR3021269T3 (en) 1997-01-31
EP0600762A1 (fr) 1994-06-08
JPH06293728A (ja) 1994-10-21
NO934338D0 (no) 1993-11-30
FI112211B (fi) 2003-11-14
FI935318A (fi) 1994-06-03
CZ284958B6 (cs) 1999-04-14
CA2110437A1 (en) 1994-06-03
KR940014435A (ko) 1994-07-18
CZ262293A3 (en) 1994-06-15
DE69303583T2 (de) 1996-11-21
ATE140215T1 (de) 1996-07-15
SK280286B6 (sk) 1999-11-08
RU2114823C1 (ru) 1998-07-10
SK135793A3 (en) 1994-06-08
JP2945261B2 (ja) 1999-09-06
NZ250330A (en) 1995-06-27
UA39920C2 (uk) 2001-07-16
DK0600762T3 (da) 1996-11-11
EP0600762B1 (fr) 1996-07-10
CN1095709A (zh) 1994-11-30
FR2698628A1 (fr) 1994-06-03
CA2110437C (en) 1999-04-13
FR2698628B1 (fr) 1995-02-17
AU5188393A (en) 1994-06-16
HUT65782A (en) 1994-07-28
TW311132B (fi) 1997-07-21
HU9303406D0 (en) 1994-03-28

Similar Documents

Publication Publication Date Title
DK0580502T3 (da) 3-(hydroxybenzylidenyl)-indolin-2-oner og farmaceutiske sammensætninger indeholdende disse
FI935318A0 (fi) 15-deoxispergualinanaloger, foerfarande foer deras framstaellning samt deras anvaendning i terapi
FI943508A (fi) Pyridiinikarboksimidamidiyhdisteet ja niiden käyttö
IL113011A (en) R-mandelic acid salt of (2s,3s)-3- (2-methoxybenzylamino)-2- phenylpiperidine
KR910700089A (ko) 히드로클로로플루오로프로판의 공비 조성물 또는 공비형 조성물
ES2037666T3 (es) Utilizacion de las fenil-naftiridinas.
ES2146606T3 (es) Metodo para limpiar alfombras.
DK0623620T3 (da) 5-HT3-pyrrolopyrazinderivater
DK0520372T3 (da) Inositol-phosphat-analoger som calciumantagonistiske stoffer
HU896173D0 (fi)
FI894653A0 (fi) Stabila oxapenem-3-karboxylsyror och deras anvaendning som b-laktamasfoerhindrare.
NO903291L (no) Renin-hemmende aminooligohydroksyderivater.
ES2095714T3 (es) Nuevas amino-alquil-cromonas, sus procedimientos de preparacion y las composiciones farmaceuticas que las contienen.
DK0472181T3 (da) 5-Amino-substituerede adenosinanaloge som immunsuppresiva
DK0552631T3 (da) Alfa-Aryl-alfa-hydroxy-beta-imidazolinyl-propionsyreamider
IL103855A0 (en) 5,6-dihydro-dibenz(b,e)azepin-6,11-dione-11-oximes,their preparation and pharmaceutical compositions containing them
FI924769A (fi) Foerfarande foer framstaellning av substituerade indoler
DE69108139D1 (de) Verwendung von 5'-Vinylhalo-aristeromycin/adenosin-Analoga als Immunsuppressiva.

Legal Events

Date Code Title Description
MA Patent expired